Position in KURA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,174,646
+$493,601 QoQ
Shares Held
198,236
-4.1% QoQ
Ownership
0.223%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#54
of 220 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 0%
Shared 99%
None 1%
Common Shares in KURA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Invesco Ltd. holds $14,420,023,301 across 296 Biotechnology names. KURA ranks #115 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
8,043,052 | $3,995,225,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,940,665 | $2,457,162,245 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,754,318 | $1,130,162,341 | |
| 4 | INCY |
Incyte Corp
|
4,080,461 | $462,561,050 | |
| 5 | ARGX |
Argenx SE
|
443,990 | $411,920,598 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
1,671,684 | $409,178,086 | |
| 7 | MRNA |
Moderna, Inc.
|
5,780,299 | $404,794,337 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
1,201,644 | $379,827,645 |
All Filings in KURA
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,174,646 | 198,236 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,681,045 | 206,771 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $2,175,352 | 209,370 | Shares | Defined | 2026-02-19 | |
| 2025-09-30 | $1,616,778 | 182,687 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $812,016 | 140,731 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $641,623 | 97,216 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $585,640 | 67,238 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $1,298,215 | 66,439 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $4,719,206 | 229,199 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $6,699,153 | 314,072 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $994,044 | 69,127 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $537,121 | 58,895 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $613,469 | 57,984 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $735,034 | 60,101 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $859,664 | 69,272 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $946,787 | 69,311 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,318,017 | 71,905 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $1,006,559 | 62,597 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $25,208,778 | 1,800,627 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $56,192,619 | 3,000,140 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $31,791,870 | 1,524,790 | Shares | Defined | 2021-08-17 | |
| 2021-03-31 | $47,923,641 | 1,695,212 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $9,240,068 | 282,917 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $9,547,546 | 311,604 | Shares | Defined | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||